A PopulationBased Study of Pharmacogenetics and Glaucoma

Catherine McCarty, PhD, MPH
Marshfield Clinic Research Foundation (Marshfield, WI)
Year Awarded:
2005
Grant Duration:
April 1, 2005 to March 31, 2007
Disease:
Glaucoma
Award Amount:
$89,430
Grant Reference ID:
G2005044
Award Type:
Standard
Award Region:
US Midwestern

A PopulationBased Study of Pharmacogenetics and Glaucoma

Details

Beta-blockers are a common class of medication used to lower intraocular pressure. Interestingly, this same class of medications is used orally to treat high blood pressure, and genetics have been shown to play a role in how a person responds to this medication. Dr. McCarty believes that genetics is also associated with how a person responds to a prescription for medication to lower intraocular pressure. Her goal is to ultimately improve treatment of patients with glaucoma and ocular hypertension. In the future this study may lead to an assessment as to whether prescription medications based on genotype would improve cost effectiveness and preserve visual function in people with glaucoma and intraocular hypertension.
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.